Streetbeat News

Analyst Ratings

UGRO

Small Cap Consumer Research analyst Eric Beder has reiterated a Buy rating on Urban-gro (NASDAQ:UGRO) and maintained a price target of $8.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 7:11 pm

HLI

Houlihan Lokey (NYSE:HLI) has received mixed analyst ratings over the past three months, with a recent increase in bullish sentiment. The average 12-month price target has risen to $154.22, with a high of $190.00 and a low of $129.00. Analysts have adjusted their ratings and price targets, reflecting changing market conditions and company performance. Houlihan Lokey has shown strong financial metrics, including a 23.51% revenue growth rate, a net margin of 17.32%, and a debt-to-equity ratio of 0.24.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 7:00 pm

ZYXI

RBC Capital analyst Shagun Singh maintains an Outperform rating on Zynex (NASDAQ:ZYXI) but lowers the price target from $12 to $11.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 6:58 pm

ZBH

RBC Capital analyst Shagun Singh maintains an Outperform rating on Zimmer Biomet Holdings but lowers the price target from $130 to $120.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 6:57 pm

TFX

RBC Capital analyst Shagun Singh maintains an Outperform rating on Teleflex (NYSE:TFX) and raises the price target from $260 to $275.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 6:56 pm

PEN

RBC Capital analyst Shagun Singh has maintained an 'Outperform' rating on Penumbra (NYSE:PEN) and increased the price target from $205 to $222.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 6:54 pm

MDT

RBC Capital analyst Shagun Singh maintains a Sector Perform rating on Medtronic and raises the price target from $92 to $98.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 6:48 pm

JNJ

RBC Capital analyst Shagun Singh maintains an Outperform rating on Johnson & Johnson and raises the price target from $175 to $178.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 6:47 pm

ISRG

RBC Capital analyst Shagun Singh maintains an Outperform rating on Intuitive Surgical (NASDAQ:ISRG) and raises the price target from $515 to $525.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 6:45 pm

GMED

RBC Capital has maintained an 'Outperform' rating on Globus Medical and raised its price target from $78 to $80, indicating confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 6:42 pm